Eisai
4523.T
#1783
Rank
NZ$15.65 B
Marketcap
$55.52
Share price
0.57%
Change (1 day)
-36.21%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - P/B ratio

P/B ratio as of November 2024 : 1.58

According to Eisai's latest financial reports the company has a price-to-book ratio of 1.85174.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Eisai - P/B ratio (from 2009 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-312.40-21.71%
2022-12-313.0624.17%
2021-12-312.47-18.56%
2020-12-313.03-13.74%
2019-12-313.51-9.9%
2018-12-313.9030.01%
2017-12-313.00-4.88%
2016-12-313.15-17.77%
2015-12-313.8369.93%
2014-12-312.26-1.29%
2013-12-312.29-4.2%
2012-12-312.393.93%
2011-12-312.3010.42%
2010-12-312.08-7.82%
2009-12-312.26